The American Cancer Society recently shared a bleak figure – for the first time, new cases of cancer in the United States are expected to cross the 2-million mark.
While advancements in care have led to a steady decline in cancer deaths over the last 30 years, rising cases for many common cancers put that progress at risk. More than 313,000 new breast cancer cases are projected for 2024.
Join The Hill’s cancer summit where administration officials, lawmakers, patient advocates, doctors, and scientists weigh in on how to accelerate critical research and equity with the goal of putting an end to cancer.
The event is scheduled to begin at 8:30 a.m. EDT.
Program Segments:
Bipartisan Perspective (In conversation with Bob Cusack, Editor in Chief, The Hill)
- Rep. John Joyce (R-Pa.), Co-Sponsor, ORPHAN Cures Act
- Rep. Wiley Nickel (D-N.C.), Co-Sponsor, ORPHAN Cures Act
White House Cancer Update (In conversation with Bob Cusack, Editor in Chief, The Hill)
- Dr. Danielle Carnival, Deputy Assistant to the President, Cancer Moonshot; Deputy Director, Health Outcomes, White House Office of Science and Technology Policy
Panel Discussion: Mitigating Inequities in Cancer Care (In conversation with Bob Cusack, Editor in Chief, The Hill)
- Dr. Crystal Denlinger, CEO, National Comprehensive Cancer Network (NCCN)
- Pam Traxel, Senior Vice President, Alliance Development & Philanthropy, American Cancer Society Cancer Action Network
- Maimah Karmo, Founder and CEO, Tigerlily Foundation
Sponsor Perspective (In conversation with Kathleen Koch, Contributing Editor, The Hill)
- Mohit Manrao, SVP, Head of US Oncology, AstraZeneca
Industry Perspective (In conversation with Bob Cusack, Editor in Chief, The Hill)
- John Crowley, CEO & President, BIO
Have a question? Reach us on social media @TheHillEvents using #TheHillCancer
Sponsored by:
AstraZeneca is a science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. At AstraZeneca, we have a bold ambition to provide cures for cancer in every form. Working in partnership with all our stakeholders, we are harnessing the power of science and innovation to deliver life-changing medicines. By understanding the complexities of cancer, we hope to revolutionize oncology treatments and increase the potential to save the lives of people around the world. Learn more about our oncology work here.